IP Library Granted Patent US 10,806,609
Granted Patent B2
US 10,806,609 · App. 15/610,684 · Granted Oct 20, 2020

Vascular stenting for aneurysms

Inventors: Aaron Berez (Portola Valley, CA); Quang Tran (Atherton, CA)
Assignee: COVIDIEN LP
A61F2/852A61B17/12031A61B17/12109A61B17/12118A61B17/12172A61B17/320758A61F2/82A61F2/90A61B2017/320004A61B2017/320766A61F2/966A61F2002/067A61F2002/823A61F2002/9665A61F2210/0076A61F2230/0069A61F2250/0015A61F2250/0039A61F2250/0063
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,806,609
App. No.
15/610,684
Granted
Oct 20, 2020
Kind
B2
Abstract

Described herein are flexible implantable occluding devices that can, for example, navigate the tortuous vessels of the neurovasculature. The occluding devices can also conform to the shape of the tortuous vessels of the vasculature. In some embodiments, the occluding devices can direct blood flow within a vessel away from an aneurysm or limit blood flow to the aneurysm. Some embodiments describe methods and apparatus for adjusting, along a length of the device, the porosity of the occluding device. In some embodiments, the occluding devices allows adequate blood flow to be provided to adjacent structures such that those structures, whether they are branch vessels or oxygen-demanding tissues, are not deprived of the necessary blood flow.

Claims (30)

1. A device for reducing blood flow within an aneurysm of a blood vessel, the device comprising:

a first occluding device comprising a first tubular lattice structure having a compressed configuration for delivery through a catheter to the aneurysm and an expanded configuration in which the first occluding device is configured to be positioned within the lumen of the blood vessel across the neck of the aneurysm; and

a second occluding device comprising a second tubular lattice structure having a compressed configuration for delivery through a catheter to the aneurysm and an expanded configuration in which the second occluding device is configured to be positioned at least partially within the first occluding device such that the second lattice structure contacts an inner wall of the first lattice structure and/or the blood vessel wall,

wherein at least one of the first lattice structure and the second lattice structure is formed of a plurality of helically-wound strands of material, and wherein at least some of the strands are a shape memory material,

wherein, when positioned across the neck of the aneurysm, the device for reducing blood flow substantially blocks blood flow into the aneurysm,

wherein the second occluding device overlaps only a portion of the first occluding device when the second occluding device is expanded within the first occluding device, and

wherein the first occluding device has a proximal portion and a distal portion, and when the first occluding device is positioned in the blood vessel lumen, the proximal portion of the first occluding device is proximal to the aneurysm while the distal portion of the first occluding device is distal to the aneurysm.

2. The device of claim 1 , wherein the first occluding device has a first porosity when unrestrained and the second occluding device has a second porosity when unrestrained different than the first porosity.

3. The device of claim 1 , wherein the second occluding device has a proximal portion and a distal portion, and wherein, when the second occluding device is positioned at least partially within the first occluding device, the proximal portion of the second occluding device is positioned distal to the proximal portion of the first occluding device and the distal portion of the second occluding device is positioned proximal to the distal portion of the first occluding device.

4. The device of claim 1 , wherein at least one of the first lattice structure and the second lattice structure is formed of 16 helically-wound strands of material.

5. The device of claim 1 , wherein at least one of the first lattice structure and the second lattice structure is formed of 48 helically-wound strands of material.

6. The device of claim 1 , wherein at least one of the first lattice structure and the second lattice structure is a braid.

7. The device of claim 1 , wherein at least one of the first lattice structure and the second lattice structure is a stent.

8. The device of claim 1 , wherein the density of at least one of the first lattice structure and the second lattice structure is about 20% to about 80% of the surface area of the respective first or second occluding device.

9. The device of claim 1 , wherein the density of at least one of the first lattice structure and the second lattice structure is about 20% to about 50% of the surface area of the respective first or second occluding device.

10. The device of claim 1 , wherein the density of at least one of the first lattice structure and the second lattice structure is about 20% to about 30% of the surface area of the respective first or second occluding device.

11. A method for reducing blood flow within an aneurysm of a blood vessel, the method comprising:

expanding a first occluding device within the blood vessel lumen across the neck of the aneurysm such that the first occluding device expands into contact with a wall of the blood vessel, wherein the first occluding device comprises a first tubular lattice structure formed of first helically-wound strands of material, and wherein at least some of the first strands are a shape memory material;

expanding a second occluding device into contact with an inner wall of the first occluding device and/or the vessel wall, wherein the second occluding device comprises a second tubular lattice structure formed of second helically-wound strands of material, and wherein at least some of the second strands are a shape memory material, wherein (a) the second occluding device overlaps only a portion of the first occluding device when the second occluding device is expanded within the first occluding device, and (b) the first occluding device has a proximal portion and a distal portion and, when the first occluding device is positioned in the blood vessel lumen, the proximal portion of the first occluding device is proximal to the aneurysm while the distal portion of the first occluding device is distal to the aneurysm; and

substantially blocking blood flow into the aneurysm via the first and second occluding devices.

12. The method of claim 11 wherein the first occluding device has a first porosity when unrestrained and the second occluding device has a second porosity different than the first porosity when unrestrained.

13. The method of claim 11 , wherein the second occluding device has a proximal portion and a distal portion, and wherein, when the second occluding device is positioned at least partially within the first occluding device, the proximal portion of the second occluding device is positioned distal to the proximal portion of the first occluding device and the distal portion of the second occluding device is positioned proximal to the distal portion of the first occluding device.

14. The method of claim 11 , wherein at least one of the first lattice structure and the second lattice structure is formed of 16 helically-wound strands of material.

15. The method of claim 11 , wherein at least one of the first lattice structure and the second lattice structure is formed of 48 helically-wound strands of material.

16. The method of claim 11 , wherein at least one of the first lattice structure and the second lattice structure is a braid.

17. The method of claim 11 , wherein at least one of the first lattice structure and the second lattice structure is a stent.

18. The method of claim 11 , wherein the density of at least one of the first lattice structure and the second lattice structure is about 20% to about 80% of the surface area of the respective first or second occluding device.

19. The method of claim 11 , wherein the density of at least one of the first lattice structure and the second lattice structure is about 20% to about 50% of the surface area of the respective first or second occluding device.

20. The method of claim 11 , wherein the density of at least one of the first lattice structure and the second lattice structure is about 20% to about 30% of the surface area of the respective first or second occluding device.

21. The method of claim 11 , wherein the aneurysm is a cerebral aneurysm.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2019
From: BEREZ, AARON LEE; TRAN, QUANG QUOC
To: CHESTNUT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 050641/0380 →
MERGER Recorded Oct 7, 2019
From: CHESTNUT MEDICAL TECHNOLOGIES, INC.
To: EV3 INC.
Reel/Frame 050641/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2019
From: EV3 LLC
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 050641/0553 →
CHANGE OF NAME Recorded Oct 7, 2019
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 050647/0135 →
CHANGE OF NAME Recorded Oct 7, 2019
From: EV3 INC.
To: EV3 LLC
Reel/Frame 050647/0179 →
Continuity (13)
Continuation 14708378 · May 11, 2015
Continuation 13796031 · Mar 12, 2013
Continuation 12431716 · Apr 28, 2009
Continuation In Part 11136395 · May 25, 2005
Continuation In Part 11136398 · May 25, 2005
Continuation In Part 11420025 · May 24, 2006
Continuation In Part 11136395 · May 25, 2005
Continuation In Part 11420027 · May 24, 2006
Continuation In Part 11136395 · May 25, 2005
Continuation In Part 11420023 · May 24, 2006
Continuation In Part 11136398 · May 25, 2005
Provisional Application 60574429 · May 25, 2004
Related Publication 20170266022A1 · Sep 21, 2017